173 related articles for article (PubMed ID: 33586444)
21. Targeted H
Deng Z; Tang M; Zhao L; Long Y; Wen Z; Cheng Y; Zheng H
Colloids Surf B Biointerfaces; 2017 Dec; 160():207-214. PubMed ID: 28934664
[TBL] [Abstract][Full Text] [Related]
22. Highly effective photothermal chemotherapy with pH-responsive polymer-coated drug-loaded melanin-like nanoparticles.
Zhang C; Zhao X; Guo S; Lin T; Guo H
Int J Nanomedicine; 2017; 12():1827-1840. PubMed ID: 28331308
[TBL] [Abstract][Full Text] [Related]
23. Polydopamine-based surface modification of paclitaxel nanoparticles for osteosarcoma targeted therapy.
Zhao L; Bi D; Qi X; Guo Y; Yue F; Wang X; Han M
Nanotechnology; 2019 Jun; 30(25):255101. PubMed ID: 30736019
[TBL] [Abstract][Full Text] [Related]
24. Vinblastine-Loaded Nanoparticles with Enhanced Tumor-Targeting Efficiency and Decreasing Toxicity: Developed by One-Step Molecular Imprinting Process.
Zhu Y; Liu R; Huang H; Zhu Q
Mol Pharm; 2019 Jun; 16(6):2675-2689. PubMed ID: 31050894
[TBL] [Abstract][Full Text] [Related]
25. Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment.
Wang Y; Wang Q; Feng W; Yuan Q; Qi X; Chen S; Yao P; Dai Q; Xia P; Zhang D; Sun F
Drug Deliv; 2021 Dec; 28(1):1695-1708. PubMed ID: 34402706
[TBL] [Abstract][Full Text] [Related]
26. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
27. Preparation, Characterization, and In Vitro/In Vivo Evaluation of 3-O-β-D-Galactosylated Resveratrol-Loaded Polydopamine Nanoparticles.
Wang B; Shan X; Lv S; Zha L; Zhang C; Dong Q; Chen W
AAPS PharmSciTech; 2021 Aug; 22(7):220. PubMed ID: 34405290
[TBL] [Abstract][Full Text] [Related]
28. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of Polydopamine-Based Curcumin Nanoparticles for Chemical Stability and pH-Responsive Delivery.
Pan H; Shen X; Tao W; Chen S; Ye X
J Agric Food Chem; 2020 Mar; 68(9):2795-2802. PubMed ID: 32031786
[TBL] [Abstract][Full Text] [Related]
30. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
31. Zwitterionic Polydopamine-Coated Manganese Oxide Nanoparticles with Ultrahigh Longitudinal Relaxivity for Tumor-Targeted MR Imaging.
Wang P; Xu X; Wang Y; Zhou B; Qu J; Li J; Shen M; Xia J; Shi X
Langmuir; 2019 Mar; 35(12):4336-4341. PubMed ID: 30813726
[TBL] [Abstract][Full Text] [Related]
32. Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy.
Sun Y; Zhao Y; Teng S; Hao F; Zhang H; Meng F; Zhao X; Zheng X; Bi Y; Yao Y; Lee RJ; Teng L
Int J Nanomedicine; 2019; 14():135-148. PubMed ID: 30613142
[TBL] [Abstract][Full Text] [Related]
33. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
[TBL] [Abstract][Full Text] [Related]
34. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy.
Lei W; Sun C; Jiang T; Gao Y; Yang Y; Zhao Q; Wang S
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110103. PubMed ID: 31546357
[TBL] [Abstract][Full Text] [Related]
35. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery.
Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J
Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209
[TBL] [Abstract][Full Text] [Related]
36. Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy.
Wang X; Wang N; Yang Y; Wang X; Liang J; Tian X; Zhang H; Leng X
Biomater Sci; 2019 Jun; 7(7):3062-3075. PubMed ID: 31140475
[TBL] [Abstract][Full Text] [Related]
37. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.
Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y
Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664
[TBL] [Abstract][Full Text] [Related]
38. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.
Zhang S; Tang C; Yin C
Drug Deliv; 2015 Feb; 22(2):182-90. PubMed ID: 24215373
[TBL] [Abstract][Full Text] [Related]
39. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
40. Polydopamine surface-modified hyperbranched polymeric nanoparticles for synergistic chemo/photothermal therapy of oral cancer.
Yin X; Li Z; Zhang Y; Zeng X; Wang Q; Liang Z
Front Bioeng Biotechnol; 2023; 11():1174014. PubMed ID: 37214280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
